CHEK2 rs141568342: What Your Genotype Means
The rs141568342 variant is a genetic change located within the CHEK2 gene, which plays a critical role in maintaining genomic stability. Research associates this variant with an increased risk of certain hereditary cancer-predisposing syndromes, including breast and colorectal cancer.
What each genotype means
Typical risk profile
This genotype represents the most common form of the CHEK2 gene found in the general population. It is not associated with the increased cancer risks linked to pathogenic variants in this gene. You should continue to follow standard age-appropriate cancer screening guidelines recommended by your healthcare provider.
This is the most common genotype observed across all global populations.
Increased cancer risk
This genotype indicates you carry one copy of a variant in the CHEK2 gene, which is a tumor suppressor involved in DNA repair. Research suggests that individuals with this variant may have a moderately increased risk for certain cancers, such as breast, colorectal, prostate, and kidney cancer. Please discuss these findings with a genetic counselor or your physician to determine if personalized screening or surveillance is appropriate for your health history.
This genotype is rare in the general population, though frequencies can vary significantly depending on ancestral background.
Elevated cancer risk
This genotype indicates you carry two copies of this CHEK2 variant. Studies suggest that individuals with biallelic variants in CHEK2 may face a higher risk of developing certain malignancies, including breast and colorectal cancer, often at an earlier age than those without these variants. It is important to consult with a medical geneticist or an oncology specialist to discuss comprehensive cancer risk assessment and management strategies.
This genotype is extremely rare in the general population.
Understanding the rs141568342 Variant
The rs141568342 variant is a specific alteration found within the CHEK2 gene, which is located on chromosome 22. In genetics, a variant like this represents a change in the DNA sequence compared to the most common version found in the general population. Because the CHEK2 gene is essential for monitoring DNA integrity, changes in its sequence can potentially disrupt its normal function. Scientists track these variants to understand how they might influence an individual's susceptibility to various health conditions. It is important to note that the presence of a variant does not guarantee the development of a disease; rather, it indicates a statistical association with a higher likelihood of certain outcomes based on large-scale population studies. Researchers use databases like ClinVar and the GWAS Catalog to document these associations and refine our understanding of how specific genetic markers contribute to complex health traits over time.
The Role of the CHEK2 Gene
The CHEK2 gene provides instructions for making a protein called checkpoint kinase 2. This protein acts as a tumor suppressor, meaning it helps prevent cells from growing and dividing too rapidly or in an uncontrolled way. When DNA damage occurs—which happens naturally during cell division or due to environmental factors—the CHEK2 protein is activated to pause the cell cycle. This pause gives the cell time to repair the damaged DNA before it continues to divide. If the damage is too severe to be fixed, the CHEK2 protein can trigger processes that lead the cell to self-destruct, preventing the propagation of mutations. When a variant like rs141568342 affects the function of this protein, the cell's ability to repair DNA or manage cell death may be compromised, which is why such variants are often studied in the context of cancer predisposition.
Research and Cancer Associations
Scientific research has established that pathogenic variants in the CHEK2 gene are associated with a moderate increase in the risk of developing certain cancers, most notably breast and colorectal cancer. Studies, including large-scale meta-analyses, have observed that individuals carrying certain CHEK2 variants may have a higher relative risk compared to the general population. However, the strength of this association can vary depending on the specific variant and the population being studied. While some variants are well-characterized, others are still being investigated to determine their exact clinical impact. It is essential to recognize that cancer is a complex disease influenced by a combination of genetic, environmental, and lifestyle factors. Having a variant in CHEK2 is only one piece of a much larger puzzle, and clinical guidelines often emphasize that risk assessment should be performed by healthcare professionals who can consider an individual's full family history and clinical context.
Interpreting Your Genetic Information
If you have received information about a CHEK2 variant, it is natural to have questions about what it means for your health. It is important to understand that genetic variants are not diagnostic on their own; they are markers that suggest a predisposition. You cannot change your genetic code, but you can use this information to have informed conversations with your doctor or a genetic counselor. They can help you understand your personal risk profile, discuss appropriate screening schedules, and explain how your family history might interact with your genetic results. Never make medical decisions based solely on a genetic report. Instead, use this information as a tool to facilitate a proactive discussion with a qualified healthcare provider who can offer personalized guidance based on the most current clinical standards and your unique medical background.
How common is this variant?
The rs141568342 variant is considered rare in the general population. Frequency can vary significantly across different ancestral groups, and large-scale genomic databases like gnomAD are typically used to estimate these proportions.
Frequently asked questions
Does having a CHEK2 variant mean I will get cancer?
No, having a variant in the CHEK2 gene does not mean you will definitely develop cancer. It simply indicates a higher statistical predisposition compared to the general population, and many people with such variants never develop the associated conditions.
What should I do if I have a CHEK2 variant?
If you are concerned about a genetic finding, you should schedule an appointment with a genetic counselor or your primary care physician. They can review your family history and determine if additional cancer screenings or specialized medical follow-up are appropriate for you.
Is CHEK2 testing standard for everyone?
Genetic testing for CHEK2 is typically recommended for individuals with a personal or strong family history of specific cancers. It is not generally recommended as a routine screening test for the average-risk population.
Can I change my risk if I have this variant?
While you cannot change your DNA, you can manage your health risks through lifestyle choices and medical surveillance. Discussing your results with a doctor allows you to create a personalized health plan that may include earlier or more frequent cancer screenings.
Sources & further reading
Educational information only, last refreshed 9/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs141568342?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29